Annual Report

In 2025, Epicentre conducted nearly one hundred projects and studies in collaboration with Médecins Sans Frontières (MSF).

These activities addressed a wide range of major health challenges affecting vulnerable populations, including tuberculosis, cholera, malaria, malnutrition, antimicrobial resistance, measles, hemorrhagic fevers, cancers, diphtheria, and hepatitis C. They drew on a variety of methodologies, including population-based surveys, qualitative studies, case-control studies, clinical trials, prospective and retrospective cohorts, as well as mathematical modelling approaches.

The year 2025 was also marked by significant reflection and organizational work, leading to the development of our 2026–2031 strategic plan. This plan responds to the need to adapt our vision and actions to the profound changes in our operational, scientific, and institutional environment. It defines five strategic priority areas, along with the principles that will guide all of our activities in the years ahead.

This 2025 activity report highlights the efforts already undertaken across these strategic areas, while also illustrating their strong interconnections.